Tocagen pitched the studys continuation as an encouraging sign for its gene therapy but its stock price fell sharply. httpsbuff.ly2HwuAOWÂ

Tocagen pitched the study’s continuation as an encouraging sign for its gene therapy, but its stock price fell sharply. https://buff.ly/2HwuAOW 

Tocagen pitched the study’s continuation as an encouraging sign for its gene therapy, but its stock price fell sharply. https://buff.ly/2HwuAOW 

More From BioPortfolio on "Tocagen pitched the study’s continuation as an encouraging sign for its gene therapy, but its stock price fell sharply. https://buff.ly/2HwuAOW "